CoChat

CSF neurofilament light chain and phosphorylated tau 181 predict disease progression in PSP

Open access
Rojas, Julio C., Bang, Jee, Lobach, Iryna V., Tsai, Richard M., Rabinovici, Gil D., Miller, Bruce L., Boxer, Adam L., AL-108-231 Investigators, Williams, David, Lafontaine, Anne Louise, Marras, Connie, Jog, Mandar, Panisset, Michael, Lang, Anthony, Parker, Lesley, Stewart, Alistair J., Corvol, Jean-Christophe, Azulay, Jean-Philippe, Couratier, Philippe, Mollenhauer, Brit, Lorenzl, Stefan, Ludolph, Albert, Benecke, Reiner, Hoglinger, Gunter, Lipp, Axel, Reichmann, Heinz, Woitalla, Dirk, Chan, Dennis, Zermansky, Adam, Burn, David, Lees, Andrew, Gozes, Illana, Boxer, Adam, Miller, Bruce L., Lobach, Iryna V., Roberson, Erik, Honig, Lawrence, Zamrini, Edward, Pahwa, Rajesh, Bordelon, Yvette, Driver-Dunkley, Erika, Lessig, Stephanie, Lew, Mark, Womack, Kyle, Boeve, Brad, Ferrara, Joseph, Hillis, Argyle, Kaufer, Daniel, Kumar, Rajeev, Xie, Tao, Gunzler, Steven, Zesiewicz, Theresa, Dayalu, Praveen, Golbe, Lawrence, Grossman, Murray, Jankovic, Joseph, McGinnis, Scott, Santiago, Anthony, Tuite, Paul, Isaacson, Stuart, Leegwater-Kim, Julie, Litvan, Irene, Knopman, David S., Schneider, Lon S., Doody, Rachelle S., Koestler, Mary, Jack, Clifford R., Van Deerlin, Viviana, Randolph, Christopher, Whitaker, Steve, Hirman, Joe, Gold, Michael, Morimoto, Bruce H. · 2018 · Neurology
Cited by 112

The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.

Abstract

Objective To determine the ability of CSF biomarkers to predict disease progression in progressive supranuclear palsy (PSP). Methods We compared the ability of baseline CSF β-amyloid1–42, tau, phosphorylated tau 181 (p-tau), and neurofilament light chain (NfL) concentrations, measured by INNO-BIA AlzBio3 or ELISA, to predict 52-week changes in clinical (PSP Rating Scale [PSPRS] and Schwab and England Activities of Daily Living [SEADL]), neuropsychological, and regional brain volumes on MRI using linear mixed effects models controlled for age, sex, and baseline disease severity, and Fisher F density curves to compare effect sizes in 50 patients with PSP. Similar analyses were done using plasma NfL measured by single molecule arrays in 141 patients. Results Higher CSF NfL concentration predicted more rapid decline (biomarker × time interaction) over 52 weeks in PSPRS (p = 0.004, false discovery rate–corrected) and SEADL (p = 0.008), whereas lower baseline CSF p-tau predicted faster decline on PSPRS (p = 0.004). Higher CSF tau concentrations predicted faster decline by SEADL (p = 0.004). The CSF NfL/p-tau ratio was superior for predicting change in PSPRS, compared to p-tau (p = 0.003) or NfL (p = 0.001) alone. Higher NfL concentrations in CSF or blood were associated with greater superior cerebellar peduncle atrophy (fixed effect, p ≤ 0.029 and 0.008, respectively). Conclusions Both CSF p-tau and NfL correlate with disease severity and rate of disease progression in PSP. The inverse correlation of p-tau with disease severity suggests a potentially different mechanism of tau pathology in PSP as compared to Alzheimer disease.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1212/wnl.0000000000004859

Cites

20 of 20 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 20 references

Research works printed but not linked: 15

  1. 10.1038/nrneurol.2016.5 · DOI
  2. 10.1002/mds.26987 · DOI · Paper page
  3. 10.1016/j.neurobiolaging.2016.02.034 · DOI · Paper page
  4. 10.1212/WNL.0000000000003154 · DOI · Paper page
  5. 10.1212/WNL.0000000000003688 · DOI · Paper page
  6. 10.1016/0022-3956(75)90026-6 · DOI · Paper page
  7. 10.1093/brain/awm032 · DOI · Paper page
  8. Satz P, Uchiyama CL, White T. Color Trails Test. Professional Manual. Odessa: Psychological Assessment Resources; 1996.
  9. Kaplan RM, Saccuzzo DP. Psychological Testing: Principles, Applications and Issues. Belmont: Wadsworth; 2009.
  10. Heaton RK, Miller SW, Taylor MJ, Grant I. Revised Comprehensive Norms for an Expanded Halstead-Reitan Battery: Demographically Adjusted Neuropsychological Norms for African American and Caucasian Adults. Lutz: PAR; 2004.
  11. 10.1371/journal.pone.0022293 · DOI
  12. Alzheimer's Disease Neuroimaging Initiative (ADNI) Protocol [online]. Available at: adni.loni.usc.edu/wp-content/uploads/2010/09/ADNI_GeneralProceduresManual.pdf. Accessed April 1, 2017.
  13. 10.1016/j.parkreldis.2016.04.006 · DOI
  14. 10.1002/mds.26694 · DOI
  15. 10.1523/JNEUROSCI.3785-09.2010 · DOI · Paper page

Cited by

See all 112

Metadata

Authors
Rojas, J. C., Bang, J., Lobach, I. V., Tsai, R. M., Rabinovici, G. D., Miller, B. L., Boxer, A. L., AL-108-231 Investigators, Williams, D., Lafontaine, A. L., Marras, C., Jog, M., Panisset, M., Lang, A., Parker, L., Stewart, A. J., Corvol, J.-C., Azulay, J.-P., Couratier, P., Mollenhauer, B., Lorenzl, S., Ludolph, A., Benecke, R., Hoglinger, G., Lipp, A., Reichmann, H., Woitalla, D., Chan, D., Zermansky, A., Burn, D., Lees, A., Gozes, I., Boxer, A., Miller, B. L., Lobach, I. V., Roberson, E., Honig, L., Zamrini, E., Pahwa, R., Bordelon, Y., Driver-Dunkley, E., Lessig, S., Lew, M., Womack, K., Boeve, B., Ferrara, J., Hillis, A., Kaufer, D., Kumar, R., Xie, T., Gunzler, S., Zesiewicz, T., Dayalu, P., Golbe, L., Grossman, M., Jankovic, J., McGinnis, S., Santiago, A., Tuite, P., Isaacson, S., Leegwater-Kim, J., Litvan, I., Knopman, D. S., Schneider, L. S., Doody, R. S., Koestler, M., Jack, C. R., Van Deerlin, V., Randolph, C., Whitaker, S., Hirman, J., Gold, M., & Morimoto, B. H.
Venue
Neurology
Published
2018-01-23
Volume
90
Issue
4
Pages
e273-e281
ISSN
  • 0028-3878 (ISSN-L)
  • 1526-632X
OpenAlex
W2780749285
Cited by
112
References
20
FWCI
5.53
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: CSF neurofilament light chain and phosphorylated tau 181 predict disease progression in PSP. https://app.cochat.ai/papers/10.1212/wnl.0000000000004859
The paper
Rojas, J. C., Bang, J., Lobach, I. V., Tsai, R. M., Rabinovici, G. D., Miller, B. L., Boxer, A. L., AL-108-231 Investigators, Williams, D., Lafontaine, A. L., Marras, C., Jog, M., Panisset, M., Lang, A., Parker, L., Stewart, A. J., Corvol, J.-C., Azulay, J.-P., Couratier, P., . . . Morimoto, B. H. (2018). CSF neurofilament light chain and phosphorylated tau 181 predict disease progression in PSP. Neurology. https://doi.org/10.1212/wnl.0000000000004859

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.